Biotech Investors & VC Firms in United States

1280 firms in this list, with a median first check of $500K. 281 of them lead rounds. Generated from verified public data and updated continuously.

Fund	HQ	Invests	Stage	Check	CRM
Mitsui Sumitomo Insurance Capital 1 person	Tokyo	JP	Pre-Seed–Late Stage	$1.1M – $198M	+ Add to CRM
Nissay Capital 1 person	Tokyo	JP	Pre-Seed–Late Stage	$610K – $71M	+ Add to CRM
Danen Capital 2 people · Leads rounds	Shenzhen	CN	Seed–Growth	—	+ Add to CRM
Levante Capital 2 people	Blaricum	NL	Seed–Growth	—	+ Add to CRM
Strategic Investment Partners Inc. 2 people	Tokyo	JP	Pre-Seed–Growth	—	+ Add to CRM
Vamare Investments Group	Athens	GR	—	—	+ Add to CRM
Stonebridge Ventures 3 people	Seoul	KR	Seed–Late Stage	$743K – $33M	+ Add to CRM
Trans-Pacific Technology Fund 8 people	Taipei	TW	Seed–Late Stage	—	+ Add to CRM
Aligned Health Ventures 1 person	—		Seed	—	+ Add to CRM
Shinhan Venture Investment 1 person	Seoul	KR	Series A–Growth	$2.2M – $45M	+ Add to CRM
TriWise Capital 1 person · Leads rounds	Shenzhen	CN	Pre-Seed–Late Stage	—	+ Add to CRM
YFY Biotech Management Company 1 person	Taipei	TW	Seed–Series B	—	+ Add to CRM
Virtus Inspire Ventures 7 people	—	HK	Seed–Series A	—	+ Add to CRM
Good Startup 5 people	Brussels	SG	Seed–Late Stage	—	+ Add to CRM
UCB Ventures 5 people	Brussels	BE	Seed–Series A	—	+ Add to CRM
Hokkaido Venture Capital, Inc. 1 person	Sapporo	JP	Pre-Seed–Late Stage	—	+ Add to CRM
CIBC 2 people	Toronto	CA	Pre-Seed–Late Stage	$1.5M – $29.2M	+ Add to CRM
AllosteRx Capital Management (Canada) Inc. 1 person	Montreal	CA	Seed–Series A	—	+ Add to CRM
Avon River Ventures 1 person · Follows rounds	—	CA	Seed–Late Stage	—	+ Add to CRM
Bioscience Equity Partners 1 person	Dubai	AE	Late Stage	—	+ Add to CRM
Fosun Pharma	Shanghai	CN	—	—	+ Add to CRM
IMM Investment	Kangnam	KR	Pre-Seed–Growth	$3M – $54M	+ Add to CRM
BioTrack Capital 6 people	Grand Cayman	CN	Seed–Late Stage	—	+ Add to CRM
Egora Holding	Martinsried	DE	Pre-Seed–Late Stage	$5.4M	+ Add to CRM